Search
Tromantadine
go.drugbank.com/drugs/DB13288ApprovedIt is an antiviral used in the treatment of herpes zoster and simplex.
Laronidase
go.drugbank.com/drugs/DB00090ApprovedInvestigationalIt contains 6 N-linked oligosaccharide modification sites. … The predicted amino acid sequence of the recombinant form, as well as the nucleotide sequence that encodes it, are identical to a polymorphic form of human a-L-iduronidase.
Alitretinoin
go.drugbank.com/drugs/DB00523ApprovedIt is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia (leukemia, promyelocytic, acute).
Ketobemidone
go.drugbank.com/drugs/DB06738InvestigationalIt also has some NMDA-antagonist properties. This makes it useful for some types of pain that don't respond well to other opioids.
Sodium stibogluconate
go.drugbank.com/drugs/DB05630ApprovedInvestigationalIt is also being investigated as an anti-tumor agent. … It belongs to the class of medicines known as the pentavalent antimonials. Sodium stibogluconate is sold in the UK as Pentostam (manufactured by GlaxoSmithKline).
Baxdrostat
go.drugbank.com/drugs/DB19090ApprovedInvestigationalIt targets aldosterone excess, a primary underlying driver of treatment resistance and organ damage in cardiovascular diseases [A275512, A275515].
Rexin G
go.drugbank.com/drugs/DB16450InvestigationalIt is under development by Epeius Biotechnologies for the potential treatment of metastatic cancer. It is also being investigated for preventing SARSCOV-2 viral entry.
Magnesium glycinate
go.drugbank.com/drugs/DB11189ApprovedInvestigationalIt is used in the treatment of magnesium deficiency.
Glofitamab
go.drugbank.com/drugs/DB16371ApprovedInvestigationalIt has a 2:1 configuration, with bivalency towards CD20 and monovalency towards CD3, and works by recruiting T-cells directly to the surface of cancerous B-cells. … Glofitamab is a full-length bispecific monoclonal antibody with affinity for both CD20 and CD3 surface antigens found on B- and T-cells, respectively.
Categories: Bispecific CD20-directed CD3 T Cell EngagerGirentuximab I-124
go.drugbank.com/drugs/DB15025InvestigationalGirentuximab I-124 is under investigation in clinical trial NCT01762592 (REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT).